AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24972254 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 319
Study 22542120 — intervention group
Group type: EXPERIMENTAL
Intervention: newly developed preeclampsia educational tool
Number of subjects: 120
Study 22542120 — intervention group
Group type: COMPARATOR
Intervention: standard pamphlet by the American College of Obstetricians and Gynecologists
Number of subjects: 120
Study 22542120 — intervention group
Group type: COMPARATOR
Intervention: no additional information
Number of subjects: 120
Study 20507811 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber dam isolation method
Number of subjects: 804
Study 20507811 — intervention group
Group type: COMPARATOR
Intervention: Cotton wool rolls isolation method
Number of subjects: 804
Study 18608843 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools (health education and physical activity)
Number of subjects: 17
Study 18608843 — intervention group
Group type: COMPARATOR
Intervention: Control schools (no intervention)
Number of subjects: 17
Study 16099352 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent truthful condition
Number of subjects: 0
Study 16099352 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent deceptive condition
Number of subjects: 0
Study 16099352 — intervention group
Group type: EXPERIMENTAL
Intervention: Random deceptive condition
Number of subjects: 0
Study 11587995 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 0
Study 11587995 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol
Number of subjects: 0
Study 11587995 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9877351 — intervention group
Group type: EXPERIMENTAL
Intervention: More information and more time to reflect
Number of subjects: 812
Study 9877351 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal level of information about side-effects
Number of subjects: 812
Study 9877351 — intervention group
Group type: EXPERIMENTAL
Intervention: More information in general
Number of subjects: 812
Study 9877351 — intervention group
Group type: EXPERIMENTAL
Intervention: Less information
Number of subjects: 812
Study 9877351 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of knowledge before participation
Number of subjects: 812
Study 9877351 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal amount of information
Number of subjects: 812
Study 7979491 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone treatment (Genotropin) 30 IU/m2/week
Number of subjects: 41
Study 7979491 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 41
Study 2596656 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrescope-guided nasotracheal intubation
Number of subjects: 60
Study 2596656 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope intubation
Number of subjects: 60
Study 1026550 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-encapsulated aspirin (Levius)
Number of subjects: 33
Study 1026550 — intervention group
Group type: COMPARATOR
Intervention: Aloxiprin (Palaprin Forte)
Number of subjects: 33
Study 30837419 — intervention group
Group type: COMPARATOR
Intervention: Direct composite (control)
Number of subjects: 210
Study 30837419 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite with fiber on occlusal level (KO)
Number of subjects: 210
Study 29945727 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI0382
Number of subjects: 61
Study 29945727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 27298051 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative pain neuroscience education (brain school)
Number of subjects: 86
Study 27298051 — intervention group
Group type: COMPARATOR
Intervention: Perioperative back school (control)
Number of subjects: 86
Study 27298051 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (usual preoperative and postoperative care)
Number of subjects: 86
Study 27298051 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 86
Study 24059744 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic doxycycline (DOXY) 200 mg per day for 7 days
Number of subjects: 57
Study 24059744 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 57
Study 21494193 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom-guided exercises + information + advice to stay active
Number of subjects: 181
Study 21494193 — intervention group
Group type: COMPARATOR
Intervention: Sham exercises + information + advice to stay active
Number of subjects: 181
Study 19244055 — intervention group
Group type: EXPERIMENTAL
Intervention: CT bronchoscopic simulation guidance
Number of subjects: 28
Study 19244055 — intervention group
Group type: COMPARATOR
Intervention: Conventional orientation using axial CT sections
Number of subjects: 28
Study 17973063 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based medicine course and case-method learning sessions (4 months, bi-weekly)
Number of subjects: 106
Study 15368623 — intervention group
Group type: EXPERIMENTAL
Intervention: Nylon sutures
Number of subjects: 61
Study 15368623 — intervention group
Group type: COMPARATOR
Intervention: Polyglactin 910 (vicryl) sutures
Number of subjects: 61
Study 15368623 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless steel sutures
Number of subjects: 61
Study 11141142 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol lowering treatments (dietary modification, drug treatment, or partial ileal bypass surgery for 1-10 years)
Number of subjects: 19
Study 11141142 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary prevention trials
Number of subjects: 19
Study 11141142 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary prevention trials
Number of subjects: 19
Study 11141142 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 19
Study 11141142 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary interventions and non-statin drugs
Number of subjects: 19
Study 11141142 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnitude of cholesterol reduction
Number of subjects: 19
Study 9088856 — intervention group
Group type: EXPERIMENTAL
Intervention: Euglycaemic insulin clamp after heavy, glycogen-depleting exercise
Number of subjects: 26
Study 9088856 — intervention group
Group type: COMPARATOR
Intervention: Euglycaemic insulin clamp after resting control day
Number of subjects: 26
Study 9088856 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of basal serum leptin concentration
Number of subjects: 26
Study 9088856 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum leptin after hyperinsulinaemia
Number of subjects: 26
Study 9088856 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal serum leptin level after exercise
Number of subjects: 26
Study 7522287 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg, once daily)
Number of subjects: 97
Study 7522287 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine retard (20 mg, twice daily)
Number of subjects: 97
Study 7522287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study 3324594 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose antibiotic prophylaxis (1 dose preoperatively)
Number of subjects: 564
Study 3324594 — intervention group
Group type: COMPARATOR
Intervention: Short-term antibiotic prophylaxis (1 dose preoperatively and 2 doses postoperatively)
Number of subjects: 564
Study 29883259 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligament balancing
Number of subjects: 129
Study 29883259 — intervention group
Group type: COMPARATOR
Intervention: Non-ligament balancing
Number of subjects: 129
Study 26349433 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy with steroid pulse therapy (TSP)
Number of subjects: 59
Study 26349433 — intervention group
Group type: COMPARATOR
Intervention: Steroid pulse monotherapy
Number of subjects: 59
Study 25320699 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharyngeal pack
Number of subjects: 140
Study 25320699 — intervention group
Group type: COMPARATOR
Intervention: No pharyngeal pack (control)
Number of subjects: 140
Study 22547304 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous platelet rich plasma (PRP) applied before sternal wiring, n = 97
Number of subjects: 196
Study 22547304 — intervention group
Group type: COMPARATOR
Intervention: Control group, n = 99
Number of subjects: 196
Study 19687468 — intervention group
Group type: EXPERIMENTAL
Intervention: HEROS PLUS Coping Skills Training (CST)
Number of subjects: 0
Study 19687468 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person long-term follow-up plus telephone-delivered psychosocial care
Number of subjects: 0
Study 18254767 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound pretreatment plus 2-minute low-voltage iontophoresis
Number of subjects: 30
Study 18254767 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard, 10-minute high-voltage iontophoresis
Number of subjects: 30
Study 18254767 — intervention group
Group type: COMPARATOR
Intervention: Sham-ultrasound plus 2-minute low-voltage iontophoresis
Number of subjects: 30
Study 16603033 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral state in OCD patients
Number of subjects: 12
Study 16603033 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom provoked state in OCD patients
Number of subjects: 12
Study 16603033 — intervention group
Group type: EXPERIMENTAL
Intervention: Path analysis in OCD patients
Number of subjects: 12
Study 16603033 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 12
Study 12755659 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 635
Study 12755659 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 635
Study 12755659 — intervention group
Group type: COMPARATOR
Intervention: Presence of Axis II personality disorder comorbidity
Number of subjects: 635
Study 11015147 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 2467
Study 11015147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleoside analogue regimens (ZDV, didanosine (ddI), ZDV + ddI, ZDV + zalcitabine (ddC))
Number of subjects: 2467
Study 11015147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleoside analogue therapy
Number of subjects: 2467
Study 8991356 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 9
Study 8991356 — intervention group
Group type: EXPERIMENTAL
Intervention: Moduretic
Number of subjects: 9
Study 8991356 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 9
Study 7958380 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ketorolac (10 mg)
Number of subjects: 100
Study 7958380 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketorolac (10 mg)
Number of subjects: 100
Study 7958380 — intervention group
Group type: COMPARATOR
Intervention: Ketogan (standard regimen)
Number of subjects: 100
Study 7958380 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 100
Study 3113357 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 320 mg/day
Number of subjects: 16
Study 3113357 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 480 mg/day
Number of subjects: 16
Study 3113357 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 16
Study 31422858 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Valsalva maneuver
Number of subjects: 0
Study 31422858 — intervention group
Group type: COMPARATOR
Intervention: Standard Valsalva maneuver
Number of subjects: 0
Study 29729530 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple viewings of UV facial photo
Number of subjects: 151
Study 29729530 — intervention group
Group type: EXPERIMENTAL
Intervention: Single viewing of UV facial photo
Number of subjects: 151
Study 29729530 — intervention group
Group type: COMPARATOR
Intervention: No viewing of UV facial photo (Control)
Number of subjects: 151
Study 27880086 — intervention group
Group type: EXPERIMENTAL
Intervention: Calendula officinalis vaginal cream
Number of subjects: 150
Study 27880086 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole
Number of subjects: 150
Study 24508849 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction leaflets for measuring child's weight and height
Number of subjects: 164
Study 24508849 — intervention group
Group type: COMPARATOR
Intervention: Simple estimated parental reports
Number of subjects: 164
Study 22089378 — intervention group
Group type: EXPERIMENTAL
Intervention: etravirine in combination with darunavir/ritonavir
Number of subjects: 0
Study 19389246 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behaviour therapy (10 weekly sessions)
Number of subjects: 180
Study 19389246 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended pharmacological treatment (pregabalin 300‐600 mg/day, with duloxetine 60‐120 mg/day if comorbid depression)
Number of subjects: 180
Study 19389246 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment at primary care level
Number of subjects: 180
Study 17244133 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health visit (OHV) invitation
Number of subjects: 0
Study 17244133 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study 15837982 — intervention group
Group type: EXPERIMENTAL
Intervention: AC-DOC (doxorubicin 60 mg/m2 plus cyclophosphamide 600 mg/m2 every 21 days followed by docetaxel 100 mg/m2 every 21 days for four cycles)
Number of subjects: 913
Study 15837982 — intervention group
Group type: COMPARATOR
Intervention: ADOC (doxorubicin 50 mg/m2 plus docetaxel 75 mg/m2 every 14 days for four cycles with filgrastim support)
Number of subjects: 913
Study 15837982 — intervention group
Group type: EXPERIMENTAL
Intervention: AC-DOC
Number of subjects: 913
Study 11995345 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking into the operating room (n = 30)
Number of subjects: 60
Study 11995345 — intervention group
Group type: COMPARATOR
Intervention: Being carried on a stretcher (n = 30)
Number of subjects: 60
Study 9562927 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin therapy
Number of subjects: 199
Study 7836705 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymopentin therapy for 6 months
Number of subjects: 30
Study 7836705 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 3343428 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-protected lower respiratory tract secretions (LRS)
Number of subjects: 24
Study 3343428 — intervention group
Group type: COMPARATOR
Intervention: Protected specimen brushes (PSB)
Number of subjects: 24
Study 3343428 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteriological count
Number of subjects: 24
Study 30076979 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-biomarker signature in training set (N=330)
Number of subjects: 330
Study 30076979 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-biomarker signature in validation set C (N=318)
Number of subjects: 330
Study 30076979 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-biomarker signature in validation set S (N=126)
Number of subjects: 330
Study 27196574 — intervention group
Group type: EXPERIMENTAL
Intervention: ibodutant 10 mg
Number of subjects: 559
Study 27196574 — intervention group
Group type: EXPERIMENTAL
Intervention: ibodutant 1 mg, 3 mg, 10 mg
Number of subjects: 559
Study 27196574 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 559
Study 27196574 — intervention group
Group type: EXPERIMENTAL
Intervention: ibodutant (all doses)
Number of subjects: 559
Study 26135376 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal exercise training
Number of subjects: 40
Study 26135376 — intervention group
Group type: COMPARATOR
Intervention: Tai Chi
Number of subjects: 40
Study 23810109 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume, energy- and nutrient-dense oral nutritional supplement (ONS) 2 × 125 mL (600 kcal, 24 g protein) per day
Number of subjects: 77
Study 23810109 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) receiving routine care
Number of subjects: 77
Study 23810109 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume, energy- and nutrient-dense ONS
Number of subjects: 77
Study 21421296 — intervention group
Group type: EXPERIMENTAL
Intervention: Virgin Olive Oil (VOO) diet
Number of subjects: 18
Study 21421296 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut diet
Number of subjects: 18
Study 21421296 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond diet
Number of subjects: 18
Study 21421296 — intervention group
Group type: COMPARATOR
Intervention: Common background diet (control for all diets)
Number of subjects: 18
Study 18346647 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator (rt-PA)
Number of subjects: 79
Study 18346647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 17154786 — intervention group
Group type: EXPERIMENTAL
Intervention: tau-dot hypothesis of braking control
Number of subjects: 0
Study 17154786 — intervention group
Group type: COMPARATOR
Intervention: direct estimation and control of ideal deceleration
Number of subjects: 0
Study 13130390 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb 761®
Number of subjects: 0
Study 13130390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11078132 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid fixation
Number of subjects: 127
Study 11078132 — intervention group
Group type: COMPARATOR
Intervention: Wire fixation
Number of subjects: 127
Study 8814584 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital subtraction radiography (DSR)
Number of subjects: 17
Study 1334792 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine (Perdipine)
Number of subjects: 37
Study 1334792 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (Towarat)
Number of subjects: 37
Study 6363156 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 105
Study 6363156 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 105
Study 6363156 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 105
Study 31735729 — intervention group
Group type: EXPERIMENTAL
Intervention: AC-OCT
Number of subjects: 400
Study 31735729 — intervention group
Group type: COMPARATOR
Intervention: C-OCT
Number of subjects: 400
Study 29887127 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutuality Scale (MS) for heart failure patients
Number of subjects: 0
Study 29887127 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutuality Scale (MS) for caregivers
Number of subjects: 0
Study 29887127 — intervention group
Group type: EXPERIMENTAL
Intervention: Mutuality Scale (MS)
Number of subjects: 0
Study 28005767 — intervention group
Group type: EXPERIMENTAL
Intervention: New bioresorbable osteosynthesis materials
Number of subjects: 12
Study 28005767 — intervention group
Group type: COMPARATOR
Intervention: Standard titanium miniplates
Number of subjects: 12
Study 25104835 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive-behavioural therapy (CBT) for 12 weeks
Number of subjects: 158
Study 25104835 — intervention group
Group type: COMPARATOR
Intervention: Behavioural stress management (BSM) for 12 weeks
Number of subjects: 158
Study 22302459 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 40
Study 20362457 — intervention group
Group type: EXPERIMENTAL
Intervention: No Touch (NT) technique
Number of subjects: 91
Study 17284861 — intervention group
Group type: EXPERIMENTAL
Intervention: CSNs10 (10 mg/kg of capsinoids)
Number of subjects: 44
Study 17284861 — intervention group
Group type: EXPERIMENTAL
Intervention: CSNs3 (3 mg/kg of capsinoids)
Number of subjects: 44
Study 17284861 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 44
Study 16214915 — intervention group
Group type: COMPARATOR
Intervention: Mail
Number of subjects: 145467
Study 16214915 — intervention group
Group type: COMPARATOR
Intervention: Mail Plus Incentive
Number of subjects: 145467
Study 16214915 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 145467
Study 12399272 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g EPA/d for 6 weeks
Number of subjects: 59
Study 12399272 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g DHA/d for 6 weeks
Number of subjects: 59
Study 12399272 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 59
Study 10410487 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarians
Number of subjects: 179
Study 10410487 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 179
Study 7595709 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel via 3-hour infusion at a starting dose of 250 mg/m2 for group I and 175 mg/m2 for group II.
Number of subjects: 49
Study 7595709 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel via 3-hour infusion without prophylactic G-CSF.
Number of subjects: 49
Study 2150166 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil (10(-4) M)
Number of subjects: 11
Study 2150166 — intervention group
Group type: COMPARATOR
Intervention: Time-matched control (n = 5)
Number of subjects: 11
Study 7027924 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin (1-g preoperative bolus)
Number of subjects: 48
Study 7027924 — intervention group
Group type: COMPARATOR
Intervention: Cephalothin (1-g preoperative dose)
Number of subjects: 48
Study 31353222 — intervention group
Group type: EXPERIMENTAL
Intervention: Human connectome
Number of subjects: 0
Study 31353222 — intervention group
Group type: EXPERIMENTAL
Intervention: Macaque connectome
Number of subjects: 0
Study 31353222 — intervention group
Group type: EXPERIMENTAL
Intervention: Primitive organisms
Number of subjects: 0
Study 31353222 — intervention group
Group type: EXPERIMENTAL
Intervention: Human connectome Laplacian matrix
Number of subjects: 0
Study 27911471 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg CoQ10 supplements per day for 12 weeks
Number of subjects: 60
Study 27911471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 27447107 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl alcohol-based sanitizer
Number of subjects: 95
Study 27447107 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride-based sanitizer
Number of subjects: 95